Related Experiment Video
Updated: Nov 21, 2025
Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
Published on: January 12, 2024
The role of mesenchymal stem cells in COVID-19 treatment
1Department of Chest Diseases, Düzce University Faculty of Medicine, Düzce, Turkey.
Abstract:
The novel coronavirus (SARS-CoV-2) pandemic has created a sense of global panic and the medical community started to search for rapid answers. Pharmaceuticals and research labs across the world are racing to find vaccines and treatments for the new coronavirus, using a variety of different technological ways. With Coronavirus disease (COVID-19), it is observed that asymptomatic symptoms turn out to be severe and fatal. By raising pyrexia, sepsis, acute respiratory distress syndrome (ARDS), and multiple organ failure are observed to develop which are not only associated with coronavirus. The treatment of the virus and the systemic inflammatory response it causes are also very important. The rapid response to infection has been well defined and comprises a complex interaction of cytokine storm, endothelial dysfunction, inflammation, and pathologic coagulation. Since the effective therapies are missing and immunological treatments may be deficient, mesenchymal stem cells (MSCs), by reason of their potent immunomodulatory ability, can have useful results in order to prevent the cytokine storm and reduce morbidity and mortality for COVID-19. The aim of this article is to discuss the potential effect of MSCs types in COVID-19 infection without definite treatment.
Insights
Mesenchymal stem cells (MSCs) show potential in treating COVID-19 by modulating the immune response and preventing severe symptoms. Their immunomodulatory abilities may reduce the cytokine storm, critical in severe coronavirus disease (COVID-19) cases.
Area of Science:
- Immunology
- Virology
- Regenerative Medicine
Background:
- The COVID-19 pandemic caused by SARS-CoV-2 presents severe health risks, including ARDS and organ failure.
- Current treatments for COVID-19 are limited, and managing the associated systemic inflammatory response is crucial.
- The body's response to SARS-CoV-2 involves a complex interplay of cytokine storm, endothelial dysfunction, and inflammation.
Purpose of the Study:
- To explore the potential therapeutic effects of mesenchymal stem cells (MSCs) in managing COVID-19.
- To discuss how MSCs might mitigate the severe inflammatory responses associated with SARS-CoV-2 infection.
- To evaluate the role of different MSC types in addressing COVID-19 complications.
Main Methods:
- Review of existing literature on MSCs and their immunomodulatory properties.
- Analysis of the mechanisms by which MSCs could counteract COVID-19-induced inflammation.
- Discussion of potential MSC-based therapeutic strategies for COVID-19.
Main Results:
- MSCs possess significant immunomodulatory capabilities.
- These capabilities suggest MSCs could help control the cytokine storm in COVID-19.
- MSCs may reduce morbidity and mortality associated with severe SARS-CoV-2 infection.
Conclusions:
- Mesenchymal stem cells offer a promising avenue for novel COVID-19 therapies.
- Their ability to modulate immune responses could be key to managing severe cases.
- Further research into MSC types and their application in COVID-19 is warranted.
More Related Videos
Related Concept Videos
01:19Mesenchymal Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:17Stem Cell Culture